Navigation Links
Drug combination shrinks breast cancer metastases in brain
Date:12/17/2007

SAN ANTONIO, Texas--A combination of a "targeted" therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer, according to data presented by Dana-Farber Cancer Institute investigators at the San Antonio Breast Cancer Symposium.

Lapatinib (Tykerb) and capecitabine (Xeloda) were paired in an extension of a Phase 2 clinical trial in which lapatinib given alone shrank brain metastases significantly in six percent of 241 patients.

In the extension trial, capecitabine was added to lapatinib in 49 patients whose metastases -- cancerous colonies in the brain spread from their primary cancer -- had progressed while on treatment. With the combination therapy, brain metastases shrank by 20 percent or more in 18 patients (37 percent) and shrank by at least 50 percent in 10 patients (20 percent), reported Nancy Lin, MD, of Dana-Farber's Breast Oncology Center.

"Very few medications have shown activity in the treatment of brain metastases, particularly in HER-2-positive metastatic breast cancer patients," said Lin, who led the study with Eric Winer, MD, director of the Dana-Farber Breast Oncology Center. "Therefore, these data are quite encouraging, and further studies are warranted."

The data (abstract 6076) will be presented on Sunday, Dec. 16 at 7 a.m. CT.

Lapatinib is an oral small-molecule drug from GlaxoSmithKline that is approved along with capecitabine for treating patients with advanced or metastatic breast cancer whose tumors are driven by the abnormal growth signal, HER-2, and who have already undergone therapy including trastuzumab (Herceptin), a taxane drug, and an anthracycline compound. Lapatinib, like trastuzumab, blocks the HER-2 signal.

Up to one-third of women with advanced, HER-2-positive breast cancer may develop metastases to the brain.

"Although radiation treatment is often effective, as women live long
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Promising drug combination may help those with ocular melanoma that has spread
2. Combination therapy reverses effects of portal hypertension in rats
3. Combination vaccines okay for infants, study shows
4. Antidepressants and painkillers - a dangerous combination
5. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Drug combination might offer hope for patients deadly brain tumors
8. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
9. Combination targets: some drugs may work best when they work together
10. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
11. Quality Control: Nissan Quest to Feature micronAir(R) Combination Cabin Air Filters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Kennewick, WA (PRWEB) October 20, 2014 ... new workflow management software application. The new module ... ensure patients receive full life-cycle quality care. , This ... to others within their practice, attach a to-do item ... see fit, and even set up reoccurring reminders for ...
(Date:10/20/2014)... Succeed is proud to announce that they ranked in the ... Every Body Walk! campaign by Kaiser Permanente. Every ... to be more active outside of the workplace. This ... end of September, was a friendly competition between organizations across ... companies gave their staff pedometers and each day, for the ...
(Date:10/20/2014)... 20, 2014 It’s hard to imagine what ... and vulnerable children around the world, it’s a reality. And ... many children are forced to walk barefoot on rocky terrain ... or play with their friends. , Buckner International's ... Air1 Radio in October to encourage support for Air1 ...
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, has recently announced ... the best Dedicated Server Hosting suppliers. Their websites ... buy high quality hosting and save money at ... Top10BestSEOHosting.com says, “We believe that iPage and GreenGeeks ... lot of the global clients enjoy using their ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its newest ... and HostMonster are the best VPS hosting suppliers ... is the method of partitioning a physical server ... the appearance and capabilities of running on someone’s ... pays close attention to VPS products and related ...
Breaking Medicine News(10 mins):Health News:My Clients Plus Announces New Workflow Management Software 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2
... LLD EZ(TM) Provides Physicians with Flexibility and Control for Lead ... ... Spectranetics,Corporation (Nasdaq: SPNC ) today announced the availability of the ... infected,pacing and defibrillation leads. The LLD EZ enables physicians to secure,the entire ...
... lifestyles are more likely to suffer from a larger ... of more than 5,000 men and women published in ... International. Researchers hope the results will help clinicians to ... managed more effectively. , According to the Boston ...
... Lehrman Group, the world,s,leading marketplace for expertise, today ... to providing patients with the,medication information they need ... iGuard Risk Ratings, iGuard Safety Alerts,and a forum ... registered,users who also want to get informed, stay ...
... brings wealth of healthcare and medical device experience to board ... ... the developer,of the first and only flexible CO2 laser scalpel enabling ... has been,elected to the company,s board of directors. Suennen, co-founder and,managing ...
... Group (USA), Inc.,(the ,Company, or ,Tiens,), (Amex: TBV ), ... ended March 31, 2008., Revenue for the first quarter ... first quarter of 2007., Net income for the first ... to net income of $6.5 million, or $0.09 per share ...
... Sampling Initiative with a Cranergy(TM) ... Fuel Station in NYC,s Penn Station, ... to energize the country and lift people from,America,s other energy ... shortage. While masters at multi-tasking, most,people need an extra boost ...
Cached Medicine News:Health News:Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads 2Health News:Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads 3Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 2Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 3Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 4Health News:Gerson Lehrman Group and iGuard, Inc. Partner to Offer Patients a Voice in Healthcare Industry Decisions 2Health News:Gerson Lehrman Group and iGuard, Inc. Partner to Offer Patients a Voice in Healthcare Industry Decisions 3Health News:Lisa M. Suennen Joins OmniGuide(R) Board of Directors 2Health News:Tiens Biotech Group (USA) Reports First Quarter Results 2Health News:Tiens Biotech Group (USA) Reports First Quarter Results 3Health News:Tiens Biotech Group (USA) Reports First Quarter Results 4Health News:Tiens Biotech Group (USA) Reports First Quarter Results 5Health News:Tiens Biotech Group (USA) Reports First Quarter Results 6Health News:Tiens Biotech Group (USA) Reports First Quarter Results 7Health News:Tiens Biotech Group (USA) Reports First Quarter Results 8Health News:Tiens Biotech Group (USA) Reports First Quarter Results 9Health News:Tiens Biotech Group (USA) Reports First Quarter Results 10Health News:Tiens Biotech Group (USA) Reports First Quarter Results 11Health News:Video: Ocean Spray Revitalizes Americans Naturally With Free Fuel for Their Bodies 2
(Date:10/17/2014)... Calif. , Oct. 17, 2014 A victim ... Orange County doctor with a history of alcohol ... ad for Yes on Prop 46 today, highlighting how Prop ... drug and alcohol testing. The ad pictures ... off reading "911-Report To ER."  Proposition 46 will enact the ...
(Date:10/17/2014)... Oct. 17, 2014 The following is ... Policy: The Green Park Collaborative (GPC) ... and private payers, medical device and pharmaceutical companies, ... experts January 12, 2015 at its first ever ... weight loss treatments.  Participants will discuss study designs ...
(Date:10/17/2014)... , Oct. 17, 2014  UBM Medica US announces ... for endocrinologists and other clinicians who treat patients with ... on effective use of insulin .  ... insulin replacement therapy – daily injections of ... progressive decline in the function of pancreatic beta cells. ...
Breaking Medicine Technology:Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4Green Park Collaborative to Discuss Comparative Effectiveness and Value of Weight Loss Treatments 2Endocrinology Network Features Special Coverage on Effective Use of Insulin 2Endocrinology Network Features Special Coverage on Effective Use of Insulin 3
... today that it will partner with Direct Relief USA ... shots to community clinic and health center patients who ... organization that works with 1,100 clinics and health centers ... and supplies for their low-income and uninsured patients.  Most ...
... Colo., Sept. 8 N30 Pharmaceuticals, LLC today announced ... a first-in-class inhibitor of s-nitrosoglutathione reductase (GSNOR). ... administered to human beings. N6022 has the potential to ... human diseases, such as asthma, chronic obstructive pulmonary disease ...
Cached Medicine Technology:CVS Caremark to Offer $5 Million in Free Flu Shots to Uninsured Patients of Community Clinics and Health Centers Beginning September 20 2CVS Caremark to Offer $5 Million in Free Flu Shots to Uninsured Patients of Community Clinics and Health Centers Beginning September 20 3CVS Caremark to Offer $5 Million in Free Flu Shots to Uninsured Patients of Community Clinics and Health Centers Beginning September 20 4N30 Pharma Initiates Phase 1 Trials of Novel Reductase Inhibitor 2
Hatsis tying forceps, titanium, long thin tying platforms....
Gills Colibri forceps, very fine pointed tips....
Fine tying forceps, curved tips, wide handle....
Castroviejo tying forceps, tying platforms, straight, 0.3 mm teeth....
Medicine Products: